Multiple sclerosis listed as No. 1 reason for medical cannabis use in Minnesota

ST. PAUL - Almost 1,400 Minnesotans are potential users of the state’s new medical cannabis program that starts July 1.
About half of the those respondents to a voluntary Minnesota Department of Health survey said they would use it for multiple sclerosis or severe muscle spasms. The next most common conditions would be cancer (17.6 percent) and epilepsy (17.5 percent).
The survey also found about 10 percent of users would be children under 18 and 8.5 percent would be people 65 and older. The vast majority -
82 percent - would be between 19 and 64.
Respondents were generally concentrated in Minnesota’s population centers across the state, but the department said participants would come from every corner of the state as residents responded from about
92 percent of Minnesota’s counties. The law authorizes eight medical-cannabis dispensing sites in Eagan, Hibbing, Maple Grove, Minneapolis, Moorhead, Rochester, St. Cloud and St. Paul.
Medical cannabis will be provided to patients as a liquid, pill or vaporized delivery method that does not require the use of dried leaves or plant form.